Julia Broadbent is a First Year PhD student investigating methods of automating and expanding the use of mass spectrometry-based proteomic testing for diagnosis of rare genetic diseases. She has a background in variant curation and computational genomics, having completed a Master of Genomics and Health at the University of Melbourne in 2024. Julia previously worked as a Research Assistant and Variant Curator across two rare disease research projects, which included coordination of the national variant curation component of the Australian Undiagnosed Disease Network (UDN-Aus). Her current research is based at the Bio21 Institute at the University of Melbourne, supervised by A/Prof David Stroud, Dr Nikeisha Caruana & A/Prof Michael Menden.